|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.952
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.855
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.843
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.793
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.786
|
Human |
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.780
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.762
|
Human |
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.741
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.699
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.676
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.673
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.673
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.643
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.641
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.630
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.602
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.584
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.578
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.565
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.552
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.551
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.541
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.539
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.537
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.516
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.515
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.510
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.508
|
Human |
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.501
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.478
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.466
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.464
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.462
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.460
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.452
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.450
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.431
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.430
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.426
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.422
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.420
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.420
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.420
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.418
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.417
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.417
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.415
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.414
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.400
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.397
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.395
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.394
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.390
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.388
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.387
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.380
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.380
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.378
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.373
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.372
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.371
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.369
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.368
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.365
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
40 |
0.365
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.358
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.355
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.353
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.349
|
|
|
|
natural killer cell chemotaxis
|
GO:0035747 |
1 |
0.346
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.343
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.341
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.336
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.336
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.332
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.319
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.314
|
Human |
|
|
protein secretion
|
GO:0009306 |
111 |
0.314
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.313
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.312
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.311
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.302
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.302
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.301
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.298
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.297
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.293
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.282
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.281
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.281
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.278
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.276
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.272
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.272
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.270
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.270
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.269
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.269
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.267
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.263
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.260
|
Human |
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.253
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.252
|
Human |
|
|
cation transport
|
GO:0006812 |
399 |
0.251
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.246
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.245
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.245
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.244
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.242
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.242
|
Human |
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.241
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.238
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.237
|
|
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
0.235
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.234
|
Human |
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.228
|
|
|
|
mammary gland epithelial cell proliferation
|
GO:0033598 |
24 |
0.226
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.225
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.224
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.223
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.222
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.222
|
|
|
|
positive regulation of immunoglobulin production in mucosal tissue
|
GO:2000558 |
1 |
0.220
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.218
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.217
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.217
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.216
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.216
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.214
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.214
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.213
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.213
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.211
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.208
|
|
|
|
positive regulation of dendritic cell dendrite assembly
|
GO:2000549 |
1 |
0.208
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.206
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.206
|
Human |
|
|
jnk cascade
|
GO:0007254 |
72 |
0.206
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.203
|
|
|
|
regulation of cd4 positive alpha beta t cell proliferation
|
GO:2000561 |
2 |
0.203
|
|
|
|
regulation of natural killer cell chemotaxis
|
GO:2000501 |
1 |
0.202
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.199
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.199
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.197
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.197
|
|
|
|
positive regulation of natural killer cell chemotaxis
|
GO:2000503 |
1 |
0.196
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.196
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.193
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.193
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.193
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.193
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.191
|
|
|
|
positive regulation of cd4 positive alpha beta t cell proliferation
|
GO:2000563 |
1 |
0.183
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.182
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.181
|
|
|
|
regulation of t helper 1 cell cytokine production
|
GO:2000554 |
1 |
0.181
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.181
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.179
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.178
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.178
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.175
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.174
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.174
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.173
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.171
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.170
|
|
|
|
regulation of cd4 positive alpha beta t cell activation
|
GO:2000514 |
24 |
0.170
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.170
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.168
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.168
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.166
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.166
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.165
|
|
|
|
mast cell proliferation
|
GO:0070662 |
4 |
0.165
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.164
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.163
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.163
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.162
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.161
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.160
|
Human |
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.160
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.158
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.157
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.157
|
|
|
|
dendritic cell dendrite assembly
|
GO:0097026 |
2 |
0.155
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.151
|
|
|
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.150
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.149
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.149
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.149
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.148
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.148
|
|
|
|
t helper 1 cell cytokine production
|
GO:0035744 |
1 |
0.147
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.147
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.145
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.145
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.144
|
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.143
|
Human |
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.143
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.142
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.142
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.142
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.142
|
|
|
|
regulation of t helper 1 cell differentiation
|
GO:0045625 |
7 |
0.141
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.141
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.140
|
Human |
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.139
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.139
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.139
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.137
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.136
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.136
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.136
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.136
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.135
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.135
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.134
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.133
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.133
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.133
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.133
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.133
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.133
|
Human |
|
|
nuclear division
|
GO:0000280 |
158 |
0.132
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.131
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.130
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.130
|
|
|
|
glycolytic process
|
GO:0006096 |
20 |
0.130
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.130
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.130
|
|
|
|
positive regulation of type 2 immune response
|
GO:0002830 |
9 |
0.129
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.129
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.129
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.129
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.129
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.128
|
|
|
|
mammary gland alveolus development
|
GO:0060749 |
22 |
0.128
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.127
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.127
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.127
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.127
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.126
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.126
|
Human |
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.125
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.125
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.125
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.123
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.123
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.122
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.121
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.121
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.121
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.120
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.120
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.120
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.119
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.118
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.118
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.118
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.117
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.117
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.116
|
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
24 |
0.116
|
|
|
|
positive regulation of t helper 1 cell cytokine production
|
GO:2000556 |
1 |
0.115
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.115
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.114
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.114
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.114
|
|
|
|
positive regulation of syncytium formation by plasma membrane fusion
|
GO:0060143 |
17 |
0.113
|
|
|
|
negative regulation of myoblast differentiation
|
GO:0045662 |
18 |
0.113
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.112
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.111
|
|
|
|
t cell differentiation involved in immune response
|
GO:0002292 |
30 |
0.111
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.111
|
Human |
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.110
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.110
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.110
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.110
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.109
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.109
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.109
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.107
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.106
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.105
|
|
|
|
regulation of immunoglobulin production in mucosal tissue
|
GO:2000557 |
1 |
0.105
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.104
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.104
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.103
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.103
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.103
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.103
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.103
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.101
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.101
|
Human |
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.101
|
|
|
|
tyrosine phosphorylation of stat5 protein
|
GO:0042506 |
9 |
0.101
|
Human |
|
|
regulation of cd4 positive alpha beta t cell differentiation
|
GO:0043370 |
21 |
0.100
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.100
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.100
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.100
|
Human |
|
|
negative regulation of myeloid cell apoptotic process
|
GO:0033033 |
11 |
0.100
|
|
|
|
mature natural killer cell chemotaxis
|
GO:0035782 |
1 |
0.099
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.097
|
|
|
|
positive regulation of t helper 2 cell cytokine production
|
GO:2000553 |
3 |
0.097
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.096
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.096
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.096
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.095
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.095
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.094
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.094
|
Human |
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.094
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.093
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.093
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.092
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.091
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.091
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.091
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.091
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.091
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.090
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.090
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.089
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.089
|
|
|
|
response to interleukin 4
|
GO:0070670 |
23 |
0.089
|
|
|
|
cd4 positive alpha beta t cell proliferation
|
GO:0035739 |
2 |
0.089
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.088
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.088
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.088
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.087
|
Human |
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.087
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.086
|
|
|
|
myeloid cell apoptotic process
|
GO:0033028 |
22 |
0.086
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.086
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.086
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.085
|
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.085
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.085
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.085
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.084
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.084
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.084
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.083
|
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.083
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.083
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.081
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.081
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.081
|
|
|
|
t cell costimulation
|
GO:0031295 |
14 |
0.081
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.081
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.080
|
|
|
|
t helper 1 cell differentiation
|
GO:0045063 |
13 |
0.080
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.079
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.079
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.079
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.078
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.078
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.078
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.077
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.076
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.076
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.076
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.076
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.075
|
|
|
|
t helper 1 type immune response
|
GO:0042088 |
25 |
0.074
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.074
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.074
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.074
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.074
|
|
|
|
hematopoietic stem cell proliferation
|
GO:0071425 |
13 |
0.074
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.074
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.073
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.073
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.072
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.072
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.072
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.071
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.071
|
|
|
|
type 2 immune response
|
GO:0042092 |
23 |
0.071
|
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.071
|
|
|
|
positive regulation of interleukin 1 secretion
|
GO:0050716 |
14 |
0.070
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.070
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.070
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.069
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.069
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.069
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.069
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.069
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.069
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.069
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.069
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.068
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.068
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.068
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.068
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.068
|
|
|
|
regulation of chronic inflammatory response to antigenic stimulus
|
GO:0002874 |
3 |
0.068
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.068
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.067
|
|
|
|
inflammatory response to wounding
|
GO:0090594 |
4 |
0.066
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.066
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.065
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.065
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.065
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.065
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.065
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.065
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.065
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.065
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.065
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.064
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.064
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.064
|
|
|
|
regulation of t helper 2 cell cytokine production
|
GO:2000551 |
3 |
0.064
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.063
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.063
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.063
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.063
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.062
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.062
|
|
|
|
regulation of mast cell proliferation
|
GO:0070666 |
4 |
0.062
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.061
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.061
|
|
|
|
negative regulation of interleukin 10 secretion
|
GO:2001180 |
2 |
0.061
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.061
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.061
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.061
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.061
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.061
|
Human |
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.060
|
|
|
|
positive regulation of b cell chemotaxis
|
GO:2000538 |
2 |
0.060
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.060
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.060
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.060
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.060
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.060
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.060
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.060
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.060
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.059
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.059
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.059
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.059
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.059
|
|
|
|
organ or tissue specific immune response
|
GO:0002251 |
13 |
0.058
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.058
|
|
|
|
inflammatory cell apoptotic process
|
GO:0006925 |
11 |
0.058
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.058
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.058
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.058
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.058
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.057
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.057
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.057
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.057
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.057
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.057
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.057
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.056
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.056
|
|
|
|
regulation of dendritic cell dendrite assembly
|
GO:2000547 |
2 |
0.056
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.056
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.056
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.056
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.056
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.055
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.055
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.055
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.055
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.054
|
|
|
|
immunoglobulin production involved in immunoglobulin mediated immune response
|
GO:0002381 |
43 |
0.054
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.054
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.054
|
|
|
|
negative regulation of leukocyte apoptotic process
|
GO:2000107 |
31 |
0.054
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.054
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.054
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.054
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.054
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.054
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.054
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.054
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.053
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.053
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.053
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.053
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.053
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.053
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
11 |
0.053
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.053
|
|
